Ad is loading...
GSXPX
Price
$68.61
Change
-$0.52 (-0.75%)
Updated
Dec 3 closing price
VSIAX
Price
$92.05
Change
-$0.53 (-0.57%)
Updated
Dec 3 closing price
Ad is loading...

GSXPX vs VSIAX

Header iconGSXPX vs VSIAX Comparison
Open Charts GSXPX vs VSIAXBanner chart's image
Goldman Sachs Small Cp Val Insghts P
Price$68.61
Change-$0.52 (-0.75%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$92.05
Change-$0.53 (-0.57%)
VolumeN/A
CapitalizationN/A
GSXPX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GSXPX vs. VSIAX commentary
Dec 04, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSXPX is a Buy and VSIAX is a StrongSell.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 57.6B vs. GSXPX (1.05B). VSIAX pays higher dividends than GSXPX: VSIAX (2.01) vs GSXPX (1.33). GSXPX was incepted earlier than VSIAX: GSXPX (7 years) vs VSIAX (13 years). GSXPX is a more actively managed with annual turnover of: 136.00 vs. VSIAX (16.00). GSXPX has a lower initial minimum investment than VSIAX: GSXPX (0) vs VSIAX (3000). GSXPX annual gain was more profitable for investors over the last year : 30.85 vs. VSIAX (26.24). VSIAX return over 5 years is better than : 63.80 vs. GSXPX (31.74).
GSXPXVSIAXGSXPX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years13 years-
Gain YTD21.83619.537112%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.05B57.6B2%
Annual Yield % from dividends1.332.0166%
Returns for 1 year30.8526.24118%
Returns for 3 years1.3926.365%
Returns for 5 years31.7463.8050%
Returns for 10 yearsN/A114.11-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
INN6.980.41
+6.24%
Summit Hotel Properties
CISS0.790.02
+2.23%
C3is
RUN11.26-0.41
-3.51%
Sunrun
SMMT17.77-0.72
-3.89%
Summit Therapeutics
BZUN2.63-0.14
-5.05%
Baozun